GlaxoSmithKline New Zealand Ltd - Upgrade Campaign

In 2002, GlaxoSmithKline was faced with the threat of losing almost $5 million dollars in sales when they had to discontinue Becotide/Becloforte, due to an international agreement to phase out CFC containing products.

Upgrade Campaign

Agency: Insight Consultants Advertiser: GlaxoSmithKline Awards: Consumer Durables (Gold)

Marketing Challenge

Over the last 10 years GlaxoSmithKline has grown to becomeNew Zealand's largest supplier of asthma medicines. Early in 2002...